Rolf W. Feenstra

SLV313 (1-(2,3-Dihydro-Benzo[1,4]Dioxin-5-yl)-4- [5-(4-Fluoro-Phenyl)-Pyridin-3-ylmethyl]-Piperazine Monohydrochloride): A Novel Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist Potential Antipsychotic Drug

Andrew C. McCreary, Jeffrey Glennon, Charles R. Ashby et al. · Neuropsychopharmacology · 2006 · 58 citations · Full text

Psychoactive Drug, Psychiatry, Medicine +10

Microwave-enhanced Goldberg reaction: a novel route to N-arylpiperazinones and N-arylpiperazinediones

Jos H.M. Lange, Lovina J. F. Hofmeyer, Floris Hout et al. · Tetrahedron Letters · 2002 · 58 citations

Cross-coupling Reaction, Engineering, Organic Chemistry +7

New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D2-receptor and serotonin 5-HT1A-receptor affinities

Rolf W. Feenstra, Janpeter de Moes, Jos J. Hofma et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 40 citations · Full text

Medicinal Chemistry, Psychoactive Drug, Psychiatry +10

In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): A novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist

Jeffrey Glennon, Guus van Scharrenburg, Eric Ronken et al. · Synapse · 2006 · 39 citations

Vitro Characterization, Dopamine Induction, Psychopharmacology +18

An efficient one-pot synthesis of novel 4-aryl-1-methyloxindoles

Adri van den Hoogenband, Jos H.M. Lange, Wouter I. Iwema‐Bakker et al. · Tetrahedron Letters · 2006 · 25 citations

Novel 4-Aryl-1-methyloxindoles, Organic Chemistry, Synthesis Method +2